Literature DB >> 22626276

Description of 2 angiogenic phenotypes in clear cell renal cell carcinoma.

Julien Edeline1, Stéphanie Mottier, Cécile Vigneau, Florence Jouan, Christophe Perrin, Selim Zerrouki, Patricia Fergelot, Jean-Jacques Patard, Nathalie Rioux-Leclercq.   

Abstract

Angiogenesis in clear cell renal cell carcinoma has received recent focus with the development of antiangiogenic therapies. Although tumor progression is known to be correlated with intratumoral and plasma levels of vascular endothelial growth factor-A, the role of tumor induced-angiogenesis remains unclear in these tumors. We analyzed the vascular network in a cohort of 73 clear cell renal cell carcinoma cases using endothelial immunostaining. We studied protein expression of vascular endothelial growth factor, Von Hippel Lindau, and carbonic anhydrase IX by immunohistochemistry, Von Hippel Lindau gene alteration by sequencing, deletion- and methylation-specific Multiplex Ligation-dependent Probe Amplification, and gene expression by pangenomic microarray and quantitative polymerase chain reaction in a subcohort of 39 clear cell renal cell carcinoma cases. We described 2 distinct angiogenic phenotypes in comparison with the normal kidney vasculature: low and high angiogenic phenotypes. The low angiogenic phenotype was associated with more aggressive prognostic factors such as T3 to T4 (62% versus 31%, P=.002), N+ (29% versus 3% P=.004), M+ (53% versus 21%, P=.004) stages, Fuhrman grade (grade 3-4: 91% versus 36%, P<.001), and intratumoral vascular endothelial growth factor expression (74% versus 28%, P<.001); was less associated with Von Hippel Lindau inactivation (56% versus 80%, P=.03); and was a predictor of poor prognosis in terms of progression-free, cancer-specific, and overall survival (log-rank test, P=.002, P=.011, and P=.035, respectively). The low angiogenic phenotype was also associated with a relative down-regulation of gene expression (platelet-derived growth factor D, N-acetyl transferase 8, and N-acetyl transferase 8 B). In conclusion, the histologic and molecular distinction between these 2 angiogenic phenotypes could help to better understand the biologic behavior of clear cell renal cell carcinoma angiogenesis and could be analyzed in a prospective study of the effects of antiangiogenic drugs.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22626276     DOI: 10.1016/j.humpath.2012.01.023

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  21 in total

1.  Clear cell renal cell carcinoma: a comparative study of histological and chromosomal characteristics between primary tumors and their corresponding metastases.

Authors:  Julien Dagher; Solène-Florence Kammerer-Jacquet; Frédéric Dugay; Marion Beaumont; Alexandra Lespagnol; Laurence Cornevin; Grégory Verhoest; Karim Bensalah; Nathalie Rioux-Leclercq; Marc-Antoine Belaud-Rotureau
Journal:  Virchows Arch       Date:  2017-05-10       Impact factor: 4.064

2.  Comprehensive Evaluation of the m6A Regulator Prognostic Risk Score in the Prediction of Immunotherapy Response in Clear Cell Renal Cell Carcinoma.

Authors:  Mingke Yu; Xuefei Liu; Han Xu; Sangyu Shen; Fajiu Wang; Dajin Chen; Guorong Li; Zongping Wang; Zhixiang Zuo; An Zhao
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

3.  Genetic Analysis Identifies the Role of HLF in Renal Cell Carcinoma.

Authors:  Chao-Yuan Huang; Shu-Pin Huang; Yu-Mei Hsueh; Lih-Chyang Chen; Te-Ling Lu; Bo-Ying Bao
Journal:  Cancer Genomics Proteomics       Date:  2020 Nov-Dec       Impact factor: 4.069

4.  Tumor-to-tumor metastasis from lung cancer: a clinicopathological postmortem study.

Authors:  Susumu Matsukuma; Takako Kono; Hiroaki Takeo; Yusuke Hamakawa; Kimiya Sato
Journal:  Virchows Arch       Date:  2013-08-03       Impact factor: 4.064

5.  Prognostic value of carbonic anhydrase IX immunohistochemical expression in renal cell carcinoma: a meta-analysis of the literature.

Authors:  Zhihong Zhao; Guixiang Liao; Yongqiang Li; Shulu Zhou; Hequn Zou; Samitha Fernando
Journal:  PLoS One       Date:  2014-11-26       Impact factor: 3.240

6.  Development and Validation of a Histological Method to Measure Microvessel Density in Whole-Slide Images of Cancer Tissue.

Authors:  Koen M Marien; Valerie Croons; Yannick Waumans; Ellen Sluydts; Stefanie De Schepper; Luc Andries; Wim Waelput; Erik Fransen; Peter B Vermeulen; Mark M Kockx; Guido R Y De Meyer
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

7.  Identification of transforming growth factor beta induced (TGFBI) as an immune-related prognostic factor in clear cell renal cell carcinoma (ccRCC).

Authors:  Guo-Wei Du; Xin Yan; Zhao Chen; Ren-Jie Zhang; Kurerban Tuoheti; Xiao-Jie Bai; Hua-Hui Wu; Tong-Zu Liu
Journal:  Aging (Albany NY)       Date:  2020-05-14       Impact factor: 5.682

8.  Prognostic Role of the Ubiquitin Proteasome System in Clear Cell Renal Cell Carcinoma: A Bioinformatic Perspective.

Authors:  Hongda Guo; Yan Li; Yaxiao Liu; Lipeng Chen; Zhengdong Gao; Lekai Zhang; Nan Zhou; Hu Guo; Benkang Shi
Journal:  J Cancer       Date:  2021-05-13       Impact factor: 4.207

9.  The pVHL172 isoform is not a tumor suppressor and up-regulates a subset of pro-tumorigenic genes including TGFB1 and MMP13.

Authors:  Pauline Hascoet; Franck Chesnel; Florence Jouan; Cathy Le Goff; Anne Couturier; Eric Darrigrand; Fabrice Mahe; Nathalie Rioux-Leclercq; Xavier Le Goff; Yannick Arlot-Bonnemains
Journal:  Oncotarget       Date:  2017-06-06

Review 10.  Immunotherapy in Renal Cell Carcinoma: The Future Is Now.

Authors:  Antoine Deleuze; Judikaël Saout; Frédéric Dugay; Benoit Peyronnet; Romain Mathieu; Gregory Verhoest; Karim Bensalah; Laurence Crouzet; Brigitte Laguerre; Marc-Antoine Belaud-Rotureau; Nathalie Rioux-Leclercq; Solène-Florence Kammerer-Jacquet
Journal:  Int J Mol Sci       Date:  2020-04-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.